Yoon Jean, Fonarow Gregg C, Groeneveld Peter W, Teerlink John R, Whooley Mary A, Sahay Anju, Heidenreich Paul A
Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park, California.
Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, California.
JACC Heart Fail. 2016 Jul;4(7):551-558. doi: 10.1016/j.jchf.2016.01.003. Epub 2016 Mar 9.
This study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system.
Heart failure is associated with considerable use of health care resources, but little is known about patterns in patient characteristics related to higher costs.
We obtained VA utilization and cost records for all patients with a diagnosis of heart failure in fiscal year 2010. We compared total VA costs by patient demographic factors, comorbid conditions, and facility where they were treated in bivariate analyses. We regressed total costs on patient factors alone, VA facility alone, and all factors combined to determine the relative contribution of patient factors and facility to explaining cost differences.
There were 117,870 patients with heart failure, and their mean annual VA costs were $30,719 (SD 49,180) with more than one-half of their costs from inpatient care. Patients at younger ages, of Hispanic or black race/ethnicity, diagnosed with comorbid drug use disorders, or who died during the year had the highest costs (all p < 0.01). There was variation in costs by facility as mean adjusted costs ranged from approximately $15,000 to $48,000. In adjusted analyses, patient factors alone explained more of the variation in health care costs (R(2) = 0.116) compared with the facility where the patient was treated (R(2) = 0.018).
A large variation in costs of heart failure patients was observed across facilities, although this was explained largely by patient factors. Improving the efficiency of VA resource utilization may require increased scrutiny of high-cost patients to determine if adequate value is being delivered to those patients.
本研究旨在确定退伍军人事务(VA)系统中的心衰患者年度医疗费用的差异。
心力衰竭与大量医疗资源的使用相关,但对于与较高费用相关的患者特征模式知之甚少。
我们获取了2010财年所有诊断为心力衰竭患者的VA利用和费用记录。我们在双变量分析中按患者人口统计学因素、合并症以及他们接受治疗的机构比较了VA总费用。我们分别对仅患者因素、仅VA机构以及所有因素组合进行总费用回归分析,以确定患者因素和机构对解释费用差异的相对贡献。
有117,870例心力衰竭患者,他们的平均年度VA费用为30,719美元(标准差49,180美元),其中一半以上的费用来自住院治疗。年龄较小、西班牙裔或黑人种族/族裔、被诊断患有合并药物使用障碍或在当年死亡的患者费用最高(所有p < 0.01)。各机构的费用存在差异,平均调整后费用范围约为15,000美元至48,000美元。在调整分析中,仅患者因素解释的医疗费用差异更多(R² = 0.116),相比之下患者接受治疗的机构解释的差异为(R² = 0.018)。
尽管心力衰竭患者的费用差异很大程度上由患者因素解释,但各机构之间仍存在差异。提高VA资源利用效率可能需要加强对高费用患者的审查,以确定是否为这些患者提供了足够的价值。